Cardiac troponin and skeletal muscle oxygenation in severe post-partum haemorrhage by Heyer, Laurent et al.
Available online http://ccforum.com/content/13/S5/S8
Page 1 of 6
(page number not for citation purposes)
Abstract
Introduction: Cardiac troponin has been shown to be elevated in
one-half of the parturients admitted for post-partum haemorrhage.
The purpose of the study was to assess whether increased cardiac
troponin was associated with a simultaneous alteration in haemo-
globin tissue oxygen saturation in peripheral muscles in post-
partum haemorrhage.
Methods: Tissue haemoglobin oxygen saturation of thenar
eminence muscle (StO2) was measured via near-infrared spectro-
scopy technology. Two sets of StO2 parameters (both isolated
baseline and during forearm ischaemia–reperfusion tests) were
collected at two time points: upon intensive care unit admission
and prior to intensive care unit discharge. Comparisons were
performed using Wilcoxon paired tests, and univariate associations
were assessed using logistic regression model and Wald tests.
Results: The 42 studied parturients, admitted for post-partum
haemorrhage, had clinical and biological signs of severe blood
loss. Initial cardiac troponin I was increased in 24/42 parturients
(0.43 ± 0.60 μg/l). All measured parameters of muscular haemo-
globin oxygen saturation, including Srecovery, were also altered at
admission and improved together with improved haemodynamics,
when bleeding was controlled. Multivariate analysis showed that
muscular  Srecovery <3%/second at admission was strongly
associated with increased cardiac troponin.
Conclusions: Our study confirmed the high incidence of increased
cardiac troponin, and demonstrated the simultaneous impairment
in the reserve of oxygen delivery to peripheral muscles in
parturients admitted for severe post-partum haemorrhage.
Introduction
Severe post-partum haemorrhage (PPH) remains one of the
two leading causes of maternal death despite the use of
intensive care unit (ICU) facilities [1-3]. We have previously
suggested that, in addition to blood loss and the occurrence
of haemorrhagic shock, increased plasma cardiac troponin I
with electrocardiogram tracings suggestive of myocardial
ischaemia may account for the morbidity associated with PPH
[4]. Increased cardiac troponin was associated with low arterial
blood pressure, increased heart rate (>115 beats/minute) and
the use of catecholamines, suggesting an unbalanced
myocardial oxygen consumption/delivery ratio. Whether the
abnormal oxygen consumption/delivery ratio is only present in
the myocardium or is a global phenomenon involving other
organs, in severe PPH, remains to be elucidated.
The recent application of near-infrared spectroscopy to ICU
patients allows continuous and non-invasive measurement of
tissue haemoglobin oxygen saturation (StO2) in the thenar
eminence muscle [5,6]. StO2 was obtained via the ratio of
oxygenated and deoxygenated haemoglobin measured by
near-infrared spectroscopy [7,8]. A low StO2 value has been
suggested to predict organ dysfunction [9,10]. In addition to
static StO2 measurements, a forearm ischaemia/reperfusion
test was recently applied in patients to allow dynamic
measures of StO2  [11,12]. Inflation of a cuff around the
patient’s arm decreases StO2, which recovers when the cuff
is released. The slope of StO2 recovery is altered in septic
shock parturients [11,13]. Similar measurements have not
been performed in haemorrhagic conditions.
We accordingly postulated that increased cardiac troponin
might be associated with impaired oxygen consumption/
Research 
Cardiac troponin and skeletal muscle oxygenation in severe
post-partum haemorrhage
Laurent Heyer1, Alexandre Mebazaa1, Etienne Gayat1, Matthieu Resche-Rigon2, 
Christophe Rabuel1, Eva Rezlan1, Anne-Claire Lukascewicz1, Catharina Madadaki1, 
Romain Pirracchio1, Patrick Schurando1, Olivier Morel3, Yann Fargeaudou4 and Didier Payen1
1AP-HP, Department of Anesthesiology and Critical Care Medicine, University Paris 7, Hôpital Lariboisière, 2 Rue Ambroise Pare, 75010 Paris, France
2Department of Biostatistics and Clinical Epidemiology, Saint-Louis University Hospital, Assistance Publique – Hôpitaux de Paris, INSERM U717,
French National Institute for Health and Medical Research, Hopital Saint Louis, 12 Rue Claude Viellefaux, 75010 Paris, France
3Department of Radiology, University Paris 7, Hôpital Lariboisière, 2 Rue Ambroise Pare, 75010 Paris, France
4Department of Gynecology and Obstetrics, University Paris 7, Hôpital Lariboisière, 2 Rue Ambroise Pare, 75010 Paris, France
Corresponding author: dpayen1234@aol.com
Published: 30 November 2009 Critical Care 2009, 13(Suppl 5):S8 (doi:10.1186/cc8006)
This article is online at http://ccforum.com/content/13/S5/S8
© 2009 BioMed Central Ltd
ICU = intensive care unit; PPH = post-partum haemorrhage; Socclusion = slope of tissue haemoglobin oxygen saturation decrease; Srecovery = slope of
tissue haemoglobin oxygen saturation ascent; StO2 = tissue haemoglobin oxygen saturation.Critical Care    Vol 13 Suppl 5 Heyer et al.
Page 2 of 6
(page number not for citation purposes)
delivery ratio in peripheral muscles. The haemoglobin tissue
oxygen saturation of thenar muscle was therefore measured,
before and after rescue therapy, in parturients admitted for
blood loss related to PPH.
Parturients and methods
Forty-two parturients with severe PPH, defined as blood loss
>1,000 ml associated with haemorrhagic shock [14-16], were
included in the present study. All parturients had attended
primary-care centres located within or around Paris (Ile-de-
France region) and were transferred to our centre when locally
available treatment options became inefficient in controlling
the bleeding. Our tertiary-care centre is specialized in severe
PPH with standardized management procedures including
two major therapeutic options: when bleeding still persists,
haemostatic surgery and/or an angiography with uterine
embolization is performed; or, if the bleeding has stopped, the
patient is monitored under intermediate care. Eight parturients
with no PPH were also studied as a control group.
The following items were collected: medical history,
obstetrical characteristics as obstetric procedure, details on
the medical treatment, the type of surgical intervention
performed, and the rate of blood transfusion. The following
variables, previously described as indicators of bleeding
intensity [4], were recorded during the first hour of ICU
admission and at ICU discharge: the lowest systolic blood
pressure and diastolic blood pressure, the highest heart rate,
the lowest pH (IU), haemoglobin, prothrombin time (%) and
fibrinogen (normal range = 2 to 4 g/l), and the highest lactate
(normal range = 0.7 to 2.1 mmol/l) and troponin I level
(normal range <0.04 μg/l).
Quantification of haemoglobin saturation in the thenar
eminence muscle
Near-infrared spectroscopy technology uses the principles of
light transmission and absorption to non-invasively measure
the ratio of oxygenated and deoxygenated haemoglobin
within arterioles, capillaries, and venules of thenar skeletal
muscle [17]. The location of thenar eminence was chosen
because of little interference with skin or fat tissue on the
obtained signal and because interstitial oedema is limited
[7,18,19]. StO2 was measured via a tissue spectrometer
(InSpectra™ Model 325; Hutchinson Technology, Hutchin-
son, MN, USA) linked to a probe placed on the thenar
eminence. This probe contains two fibre-optic endings with a
spacing of 25 mm, allowing a 23 mm in-depth measurement
[7,20,21]. StO2 was continuously monitored and recorded
using InSpectra™ software.
In addition to baseline measurements, StO2 was also
measured during ischaemia–reperfusion tests performed in
all our parturients. Measurement consisted of a cessation of
forearm blood flow induced by a rapid pneumatic cuff inflation
above the elbow to a pressure 50 mmHg above the systolic
arterial pressure. During this no-flow phase, thenar StO2
declines; when it reached a value of 40%, the pneumatic cuff
was immediately released. Figure 1 shows a representative
example of an StO2 tracing during forearm ischaemia–
reperfusion tests in one parturient. This test allowed one to
measure: during the forearm no-flow phase, the slope of StO2
decrease (Socclusion) that was previously described as an
index of forearm muscular oxygen consumption [22,23]; and,
after the cuff release, the slope of StO2 ascent (Srecovery), an
index of re-oxygenation capabilities of thenar skeletal muscle.
Both slopes were calculated from numerical values using the
least-square linear regression method. Of note, we choose
40% as a target to release the pneumatic cuff – instead of
3 minutes – because this level is safe, and because altered
oxygen consumption in diseased patients might markedly
alter StO2 at 3 minutes, which may influence the recovery
slope of StO2. The stability of the thenar skin temperature
and the absence of muscular contraction were checked
during measurements.
The baseline thenar StO2 and changes following the forearm
ischaemia–reperfusion test were recorded twice: at ICU
admission, at the time of haemorrhagic shock; and imme-
diately before ICU discharge, 12 to 24 hours after the control
of genital bleeding.
Figure 1
Thenar muscle tissue haemoglobin oxygen saturation in a patient
hospitalized for severe post-partum haemorrhage. Representative
example of thenar muscle tissue haemoglobin oxygen saturation (StO2)
at admission and at intensive care unit discharge in the same patient.
Set of measurements: StO2 at baseline, during cuff inflation (Socclusion)
and after cuff release (reperfusion phase, Srecovery). cTnI, cardiac
troponin I (normal range <0.04 μg/l).The protocol was approved by the Ethics Committee of the
French Society of Intensive Care (CE-SRLF 07-185).
Statistical analysis
Data are summarized as frequencies and percentages for
categorical variables. Quantitative variables are presented as
the median (25th to 75th percentiles) or as the mean ±
standard deviation – except for Srecovery, for which a histogram
is given.
Comparisons between measurements at admission and at
the time bleeding was stopped were performed using
Wilcoxon paired tests.
Univariate associations between plasma troponin I level
>0.04 μg/l and variables at admission were assessed using
the logistic regression model and Wald tests. All factors with
P <0.05 in the univariate analysis were included in a multiple
logistic regression model. Variable selection was performed
using a backward procedure. Odds ratios with their 95%
confidence intervals are presented as a measure of asso-
ciation. Furthermore, the receiver operating characteristic
curve of Srelease was used to detect association with troponin
I level >0.04 μg/l; the area under the curve is presented.
All tests were two-sided at the 0.05 significance level.
Analyses were performed using the R statistical package [24].
Results
Demographic data and management of post-partum
haemorrhage
Data from 42 consecutive parturients admitted for PPH are
presented in Table 1. Twenty-three parturients were success-
fully managed medically and 19 parturients needed emer-
gency invasive procedures: two had an immediate hysterec-
tomy and 17 underwent angiography with a subsequent
arterial embolization (predominantly in uterine arteries), which
was successful for 15 of them and the last two parturients
needed a combined hysterectomy and arterial embolization.
Parturients required a median of 3 (0 to 7) units red blood
cells. All parturients survived with a length of stay in our
centre (intermediate care/ICU) of 2.1 (1.3 to 4.1) days.
Haemodynamics, biology and haemoglobin tissue
oxygen saturation
Table 2 shows the impact of blood loss on the haemo-
dynamic and biological parameters measured at admission.
This includes low blood pressure, elevated heart rate, low
haemoglobin (7.1 (6.3 to 8.7) g/dl), increased serum lactate
at 2.8 ± 1.3 mmol/l (normal range = 0.7 to 2.1 mmol/l) and
increased serum cardiac troponin I in 24/42 parturients
(0.43 ± 0.60 μg/l, while <0.04 μg/l in the other 18
parturients). The three parturients requiring catecholamines
all had an increased troponin I level. Control parturients
(n = 8) had stable haemodynamics and haemoglobin at 10.8
(10.5 to 11.0) g/dl.
At admission, haemoglobin tissue oxygen saturation showed
an initial StO2 at 82% (78 to 86%), Socclusion at –0.25%/
second (–0.33 to –0.19%/second) and Srecovery at 4.5%/
second (2.4 to 6.0%/second). Control parturients had StO2
at 88% (80 to 90%), Socclusion at –0.44%/second (–0.66 to
–0.44%/second) and Srecovery at 7.6%/second (5.9 to 9.5%/
second) (all P <0.0001 versus admission for severe PPH).
Figure 2 shows that Srecovery at admission exerted a bimodal
distribution in our 42 severe PPH parturients, with the
threshold at 3%/second. Figure 2 also shows that Srecovery
<3%/second was associated with 87% of troponin-positive
patients while Srecovery >3%/second was associated with only
37% of troponin-positive patients (P <0.002). The receiver
operating characteristic curve confirms that the Srecovery
threshold of 3%/second had the optimal sensitivity and
specificity for the association with increased cardiac troponin
(Figure 3). Of note, neither baseline StO2 nor  Socclusion
showed a similar bimodal distribution or was associated with
levels of cardiac troponin (data not shown).
Table 2 shows that the actions taken to control genital tract
bleeding restored haemodynamic and biological parameters
and improved all measured parameters of StO2 (Socclusion and
Srecovery). Figure 1 shows a representative example of improve-
ment of both Socclusion and  Srecovery after bleeding was
controlled by uterine embolization.
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Table 1
Patient characteristics
Characteristic Value
Agea 34 (30 to 36)
Gravidity 2 (1 to 3)
Parity 2 (1 to 3)
Mode of delivery
Vaginal 28 (67%)
Caesarean section 14 (33%)
Forceps 10 (24%)
Mode of treatment in our centreb
Medical management alone 23 (55%)
Embolization 17 (40%)
Hysterectomy 4 (10%)
Sulprostone 40 (95%)
Catecholamines 3 (7%)
Red blood cells (units)c 3 (0 to 7)
Mechanical ventilation 8 (19%)
Data are presented as the median (interquartile range) or n (% of
total); n = 42. aSeven patients had both general and regional
anaesthesia. bTwo parturients had both embolization and
hysterectomy. cTotal including before admission and the care unit stay
in our centre.Factors associated with increased cardiac troponin in
post-partum haemorrhage parturients
Univariate analysis showed that, among all measured para-
meters, heart rate >115/minute and muscular Srecovery <3%/
second, both measured at admission, were independently
associated with increased cardiac troponin. The adjusted
odds ratios were 5.0 (95% confidence interval = 1.1 to 21.9,
P = 0.03) for heart rate >115/minute and 11.2 (95% confi-
dence interval = 2.1 to 60.0, P = 0.005) for muscular Srecovery
<3%/second. Furthermore, multivariate analysis showed that
Srecovery <3%/second at admission was strongly associated
with increased cardiac troponin, with an odds ratio of 8.8
(95% confidence interval = 1.6 to 49.0, P = 0.01).
Discussion
The present study confirms the high incidence of increased
cardiac troponin and, more importantly, showed for the first
time a simultaneous deterioration in all measured parameters
of StO2, at admission, in our PPH parturients.
StO2 was assessed using the near-infrared spectroscopy
device that measures the ratio of oxygenated and deoxy-
genated haemoglobin within arterioles, capillaries, and venules
of skeletal muscle with little influence from skin or other
tissues [7,20]. The thenar StO2 was previously described to
be 87 ± 6% in healthy volunteers and 80 ± 12% in patients
with blood loss [10]. Our study results are in line with those
published results as we found a median StO2 of 88% (80 to
90%) in control parturients, and of 82% (78 to 86%) at
admission and 87% (80 to 91%) before ICU discharge in our
PPH parturients.
During the forearm ischaemia–reperfusion test [22,25], the
slope of StO2 decrease during the no-flow phase (Socclusion;
Figure 1) was previously described as an index of thenar oxygen
consumption [23,26]. In our study, Socclusion was impaired at
admission when parturients were haemodynamically unstable
(–0.25%/second) compared with –0.32 %/second at dis-
charge. This suggests that thenar oxygen consumption was
low at admission and increased over time when bleeding was
controlled and haemodynamics improved.
The slope of thenar StO2 ascent after the ischaemic no-flow
challenge (Srecovery) was used to quantify the post-ischaemic
reoxygenation capabilities in the thenar muscle [27,28]. Our
study shows that Srecovery was low in our PPH parturients at
admission and improved towards levels measured in parturients
with no PPH. As described above, the low Srecovery at admis-
sion cannot be explained by a high oxygen consumption in
the thenar muscle of our parturients. Accordingly, the low
Srecovery measured at admission is probably explained by an
impaired post-ischaemic reserve of oxygen delivery in the
thenar muscle at the time of admission for PPH.
We have previously described a high incidence of increased
cardiac troponin that was associated with low blood
pressure, high heart rate, low haemoglobin level, T-wave
inversions and echocardiography changes in severe PPH [4].
Several hypotheses, including subendocardial ischaemia due
to a mismatch between myocardial oxygen supply and
demand [29,30], have been proposed – but the mechanisms
by which these features cause increases in cardiac troponin
in the absence of acute coronary syndrome in PPH par-
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Table 2
Haemodynamic, biological and NIRS measurements during first hour of admission and when bleeding was stopped
Variable At admission Intensive care unit discharge P-value
Hemodynamic
Systolic blood pressure (mmHg) 106 (100 to 120) 122 (110 to 130) 0.005
Diastolic blood pressure (mmHg) 53 (45 to 66) 60 (50 to 69) 0.28
Heart rate (beats/minute) 105 (90 to 134) 90 (70 to 100) 0.0002
Biology
pH (IU) 7.37 (7.34 to 7.42) 7.42 (7.40 to 7.43) 0.0004
Lactate (mmol/l) 2.4 (1.9 to 3.5) 1.4 (0.9 to 2.0) <0.0001
Haemoglobin (g/dl) 7.1 (6.3 to 8.7) 8.2 (7.4 to 9.6) <0.0001
Prothrombin time (%) 63 (48 to 73) 83 (74 to 94) <0.0001
Fibrinogen (g/l) 2.1 (1.3 to 2.9) 3.6 (3.1 to 4.5) <0.0001
Cardiac troponin I (μg/l) 0.07 (0.02 to 0.18) 0.02 (0.02 to 0.08) 0.0008
NIRS measurements
StO2 (%) 82 (78 to 86) 87 (80 to 91) <0.0001
Socclusion (%/second) –0.25 (–0.33 to –0.19) –0.32 (–0.4 to –0.23) 0.001
Srecovery (%/second) 4.5 (2.4 to 6.0) 5.8 (4.6 to 7.0) 0.0003
Data presented as median (interquartile range); n = 42. P-values were calculated using the Wilcoxon test. NIRS, near-infrared spectroscopy;
Socclusion, slope of tissue haemoglobin oxygen saturation decrease; Srecovery, slope of tissue haemoglobin oxygen saturation ascent; StO2, tissue
haemoglobin oxygen saturation.turients remain uncertain. Our study revealed that increased
cardiac troponin was strongly associated with muscular
Srecovery <3%/second and not with baseline StO2 or with
Socclusion. Muscular Srecovery <3%/second was even more
strongly associated (odds ratio >10) with increased cardiac
troponin than a high heart rate in our PPH parturients. This
might suggest – if the increased cardiac troponin was related
to a mismatch between myocardial oxygen supply and
demand, and if simultaneous impairments observed in the
myocardium and in peripheral muscle were related to similar
mechanisms – that increased cardiac troponin was rather due
to an impaired myocardial oxygen supply than to an increased
oxygen demand. This hypothesis needs further evaluation.
In summary, our study confirmed the high incidence of
increased cardiac troponin and demonstrated a simultaneous
impairment in the reserve of oxygen delivery to the peripheral
muscles in our severe PPH parturients when admitted with
unstable haemodynamics. These data confirm that haemo-
dynamic management in this patient subpopulation should
focus on the early simultaneous restoration of both blood
pressure and haemoglobin levels and, if possible, the
reduction of tachycardia.
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